13F

Stock

Apimeds Pharmaceuticals Us I

Ticker not mapped · held by 6 managers

Reported value

$803K

Holders

6

+1 new · −3 exited

Holders’ est. mark

$46.2K

Price effect on 3 books still in the name

Largest holder

$490.3K

Hemenway Trust Co LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Hemenway Trust Co LLC274K$490.3K$40.9KAdded$40.9K
VANGUARD CAPITAL MANAGEMENT LLC95.9K$171.6KHeld
GEODE CAPITAL MANAGEMENT, LLC40.1K$71.7K$5.21KAdded$14.4K
VANGUARD FIDUCIARY TRUST CO24K$43KHeld
TWO SIGMA SECURITIES, LLC10.6K$18.9KNew
UBS Group AG4.19K$7.49K$87Added$6.54K

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.